Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
30.10
-2.61 (-7.98%)
At close: Nov 21, 2024, 4:00 PM
31.00
+0.90 (2.99%)
After-hours: Nov 21, 2024, 4:31 PM EST
Structure Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -110.55 | -89.62 | -51.32 | -38.05 | -15.88 |
| Depreciation & Amortization | 0.82 | 0.32 | 0.28 | 0.07 | - |
| Other Amortization | - | - | - | 0.05 | 0.02 |
| Loss (Gain) From Sale of Investments | -14.76 | -5.98 | -0.91 | 0.03 | 0.03 |
| Stock-Based Compensation | 15.06 | 8.19 | 2.51 | 1.49 | 0.57 |
| Other Operating Activities | 1.32 | 0.63 | 0.35 | 0.19 | 0.02 |
| Change in Accounts Payable | 5.13 | -0.86 | 2.15 | 1.9 | 1.02 |
| Change in Other Net Operating Assets | 1.09 | 7.83 | 0.82 | 2.17 | -0.07 |
| Operating Cash Flow | -101.9 | -79.49 | -46.12 | -32.16 | -14.28 |
| Capital Expenditures | -2.43 | -2.17 | -0.16 | -1.21 | -0.02 |
| Investment in Securities | -570.46 | -266.18 | -61.95 | 19.07 | -21.13 |
| Investing Cash Flow | -572.89 | -268.34 | -62.11 | 17.86 | -21.15 |
| Issuance of Common Stock | 816.56 | 473.1 | 0.03 | 0.01 | - |
| Repurchase of Common Stock | - | - | -0.01 | - | - |
| Other Financing Activities | -20.28 | -21.57 | -2.51 | 3.24 | -0.16 |
| Financing Cash Flow | 796.28 | 451.53 | 29.01 | 103.25 | 25.84 |
| Net Cash Flow | 121.49 | 103.7 | -79.21 | 88.95 | -9.59 |
| Free Cash Flow | -104.33 | -81.66 | -46.28 | -33.37 | -14.3 |
| Free Cash Flow Per Share | -2.09 | -2.22 | -14.49 | -12.30 | -6.85 |
| Levered Free Cash Flow | -73.65 | -51.38 | -26.08 | -18.79 | - |
| Unlevered Free Cash Flow | -73.65 | -51.38 | -26.08 | -18.76 | - |
| Change in Net Working Capital | -8.62 | -6.51 | -4.14 | -4.45 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.